- Home
- SXTC vs AVX Comparison
SXTC vs AVX Comparison
Compare SXTC & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTC | AVX |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.5M | 151.8M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SXTC | AVX |
|---|---|---|
| Price | $1.40 | $1.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 224.2K | 168.5K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,740,907.00 | $1,319,011.00 |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8001.54 |
| 52 Week Low | $0.95 | $1.43 |
| 52 Week High | $7.84 | $25.38 |
Technical Indicators
Market Signals| Indicator | SXTC | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 50.67 | N/A |
| Support Level | $1.35 | N/A |
| Resistance Level | $1.42 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 45.00 | 0.00 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.